References
- Albertsson P. A., Emanuelsson H., Milsom I. Beneficial effects of treatment with transdermal estradiol-17-beta on exercise-induced angina and ST segment depression in syndrome X. Int J Cardiol 1996; 54: 13–20
- Collins P., Rosano G. M., Jiong C., Linsay D., Sarrel P. M., Poole-Wilson P. A. Cardiovascular protection by oestrogen a calcium antagonist effect. Lancet 1993; 341: 1264–1265
- Findlay J. K. Angiogenesis in reproductive tissues. J Endcrinol 1986; 111: 357–366
- Giordano F J, Piny P., McKinnan M. D., Nozaki S., DeMaria A. N., Dillmann W. H., Mathieu-Costello O., Hammond H. K. Intracoronary gene transfer of fihroblast growth factor-5-increases blood flow and contractile function in an ischemic region of the heart. Nature Medicine 1996; 2: 534–539
- Grodstein F., Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Diseases 1995; XXXVII: 199–210
- Grodstein F., Stampfer M., Manson J., Colditz G., Willett W., Rosner B., Speizer F., Hennekens C. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. New Eng J Med 1996; 33: 453–461
- Gruchow H. W., Anderson A. J., Barboriak J. J., Sobocinski K. A. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988; 115: 954–963
- Hale S. L., Bimbaum Y., Kloner R. A. Beta-estradiol, but not alpha-estradiol, reduce myocardial necrosis in rabbits after ischemia reperfusion. Am Heart J 1996; 132: 258–262
- Hyder S. M., Stancel G. M., Chiappetta C., Murthy L., Boettger-Tony H. L., Makela S. Uterine expression of vascular endothelial growth factor is increased by estradiol and tarnoxifen. Cancer Res 1996; 56: 3954–3960
- Kauser K., Rubanyi G. M. 17β-estradiol and endothelial nitric oxide synthase. Endothelium 1994; 2: 203–208
- Morales D. E., McGowan K. A., Grant D. S., Maheshwari S., Bhantiya D., Cid M. S., Kleinman H. K. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a marine model. Circulation 1995; 91: 755–763
- Schaper W., Ito W. D. Molecular mechanisms of coronary collateral growth. Circ Res 1996; 79: 911–919
- Stampfer M. J., Colditz G. A., Willet W. C., Manson J. E., Rosner B., Speiker F. E., Henneckens C H. Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from nurses' health study. New Eng J Med 1991; 325: 756–762
- Sullivan J. M., Zwagg R. V., Lomp G. F., et al. Post menopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988; 108: 358–363
- Unger E. F, Banai S., Shou M., Lazarous D. F., Jaklitsch M. T., Schinowitz M., Correa R., Klingbeil C., Epstein S. E. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 1994; 266: H1588–H1595
- Weinstein M. C., Schiff J. Cost-effectiveness of hormone replacement therapy in the menopause. Obstet Gynecol Surv 1983; 38: 445–455
- Wexler B. C., McMurtry J. P. Hormonal and metabolic changes during acute myocardial infarction in normotensive vs. hypertensive rats. Br J Exp Pathol 1983; 64: 124–136
- Wren B. G. The effect of oestrogen on the female cardiovascular system. Med J Aust 1992; 157: 204–208